Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT02216747 |
Date of registration:
|
13/08/2014 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Low Dose Steroids in the Treatment of Nephrotic Syndrome Relapse
NS |
Scientific title:
|
Treatment of Nephrotic Syndrome Relapse With Low Steroid Dose |
Date of first enrolment:
|
September 2014 |
Target sample size:
|
100 |
Recruitment status: |
Not yet recruiting |
URL:
|
http://clinicaltrials.gov/show/NCT02216747 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
|
Phase:
|
Phase 4
|
|
Countries of recruitment
|
Israel
| | | | | | | |
Contacts
|
Name:
|
Amit Dagan, Doctor |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
nephrology institute Shneider Children Hospital |
|
Name:
|
Amit Dagan, Doctor |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Schneider childrens Hospital Nephrology Institute |
| |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients with Idiopathic nephrotic syndrome with a flair that needs steroids
treatment.
Exclusion Criteria:
- Steroid resistance or treatment with Cyclosporin or Cellcept
Age minimum:
1 Year
Age maximum:
18 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Glomerular Disease
|
Intervention(s)
|
Drug: prednisone 60 mg/meter square Body Surface Area
|
Drug: prednisone 30 mg
|
Drug: prednisone 45 mg
|
Primary Outcome(s)
|
Nephrotic Syndrome Remission
[Time Frame: 3 days]
|
Secondary Outcome(s)
|
Remission duration
[Time Frame: Weeks]
|
Secondary ID(s)
|
RMC14 6413 CTIL
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|